GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

Rating:
Outperform
REGN
up 3,784.47 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Outperform by Credit Suisse

Posted on: Tuesday,  Nov 13, 2012  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 11/13/2012. Previously Credit Suisse rated Outperform Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on
05/01/2009., when the stock price was $13.85. Since then, Regeneron Pharmaceuticals, Inc. has gained 3784.48% as of 01/27/2016's recent price of $538.00.
If you would have followed the previous Credit Suisse's recommendation on REGN, you would have gained 3784.47% of your investment in 2462 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/13/2012 8:25 AM Buy
None
144.99
as of 12/31/2012
1 Week down  -1.13 %
1 Month down  -3.10 %
3 Months up  12.05 %
1 YTD up  208.62 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/1/2009 8:25 AM Buy
None
13.85
6/5/2008 8:25 AM Hold
None
17.60

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy